Caricamento...

Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis

BACKGROUND AND OBJECTIVES: Cough is a major symptom in cystic fibrosis. Ivacaftor is a novel drug which targets the G551D mutation and has been demonstrated to improve lung function and weight in the long term. It also improves symptoms of extra-oesophageal reflux. We wanted to evaluate the effect o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Respir Med J
Autori principali: Faruqi, Shoaib, Shiferaw, Dejene, Morice, Alyn H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Bentham Open 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299558/
https://ncbi.nlm.nih.gov/pubmed/28217196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874306401610010105
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !